DE BERNARDI ELISABETTA

Cerina, V., Pozzi, F., De Bernardi, E., Crivellaro, C., Moresco, R., Ferrarese, C., et al. (2025). Identification of Alzheimer’s disease with 18F-FDG-PET and MRI pCASL in MCI and SCD subjects: the CAPE study. Intervento presentato a: NeuroMI 2025 International Meeting: “Artificial Intelligence for Neuroscience: from basic research to clinical practice“, October 15-17, 2025, Milano, Italia. Dettaglio

Cerina, V., Rui, C., Di Cristofori, A., Ferlito, D., Carrabba, G., Giussani, C., et al. (2025). Implication of tumor morphology and MRI characteristics on the accuracy of automated versus human segmentation of GBM areas. SCIENTIFIC REPORTS, 15(1) [10.1038/s41598-025-85400-9]. Dettaglio

Monaco, L., Crivellaro, C., De Bernardi, E., Bono, F., Casati, G., Seminati, D., et al. (2025). Next-generation radiomic sequencing in non-small cell lung cancer: an alternative model to predict mutations from [18F]FDG PET/CT. THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 19 [10.1177/17534666251384433]. Dettaglio

Cerina, V., Rui, C., DE BERNARDI, E., Moresco, R., Giussani, C., Basso, G., et al. (2024). Preliminary assessment of semiautomated segmentation tool for GBM neurosurgery: a BraTS-Toolkit approach. Intervento presentato a: 19th European Molecular Imaging Meeting - EMIM (European Society of Molecular Imaging - ESMI) - 12-15 March, Porto, Portugal. Dettaglio

Cerina, V., Crivellaro, C., Morzenti, S., Pozzi, F., Bigiogera, V., Jonghi-Lavarini, L., et al. (2024). A ROI-based quantitative pipeline for 18F-FDG PET metabolism and pCASL perfusion joint analysis: Validation of the 18F-FDG PET line. HELIYON, 10(1) [10.1016/j.heliyon.2023.e23340]. Dettaglio